Marsh & McLennan Companies, Inc. (NYSE:MRSH) Receives $200.19 Consensus Target Price from Analysts

Marsh & McLennan Companies, Inc. (NYSE:MRSH) has been given a consensus rating of “Hold” by the eighteen brokerages that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $200.1875.

Several equities analysts have weighed in on the stock. Piper Sandler decreased their target price on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price on the stock in a research report on Wednesday, May 6th. Barclays reduced their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. JPMorgan Chase & Co. reduced their target price on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a research report on Thursday, April 9th. Finally, Mizuho reduced their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating on the stock in a research report on Monday, April 13th.

Insider Activity at Marsh & McLennan Companies

In other news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Numerai GP LLC increased its position in Marsh & McLennan Companies by 966.2% in the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock valued at $7,501,000 after acquiring an additional 33,729 shares during the period. Swiss Life Asset Management Ltd increased its position in Marsh & McLennan Companies by 9.5% in the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after acquiring an additional 11,648 shares during the period. Barclays PLC increased its position in Marsh & McLennan Companies by 41.7% in the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock valued at $443,844,000 after acquiring an additional 647,987 shares during the period. Sarasin & Partners LLP increased its position in Marsh & McLennan Companies by 0.9% in the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock valued at $173,411,000 after acquiring an additional 8,283 shares during the period. Finally, CSM Advisors LLC acquired a new position in Marsh & McLennan Companies in the 3rd quarter valued at about $1,180,000. Institutional investors and hedge funds own 87.99% of the company’s stock.

Marsh & McLennan Companies Stock Performance

Shares of NYSE:MRSH opened at $166.10 on Monday. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. The firm has a market capitalization of $80.24 billion, a price-to-earnings ratio of 20.76, a P/E/G ratio of 2.39 and a beta of 0.62. Marsh & McLennan Companies has a 52-week low of $156.60 and a 52-week high of $219.71.

Marsh & McLennan Companies (NYSE:MRSH) last issued its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.21 by $0.08. The company had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business’s quarterly revenue was up 7.6% on a year-over-year basis. On average, analysts expect that Marsh & McLennan Companies will post 10.38 EPS for the current fiscal year.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.